Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Pfizer
Lobbying Relationship
Bills mentioned
S.1631: Customs Facilitation and Trade Enforcement Reauthorization Act of 2009
Sponsor: Max Baucus (D-Mont.)
H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act
Sponsor: Henry A. Waxman (D-Calif.)
H.R.1548: Pathway for Biosimilars Act
Sponsor: Anna G. Eshoo (D-Calif.)
H.R.1: American Recovery and Reinvestment Act of 2009
Sponsor: David R. Obey (D-Wis.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Brian Pomper | Chief Trade Counsel to Sen. Max Baucus Chief Trade Consel to Sen. Max Baucus Chief Int'l Trade Counsel, Sen. Finance |
| Alixandria Lapp | CoS, Comm. and Pol. Dir., Comm. Dir., Rep. Smith Chief of Staff, Comm. and Policy Dir. Rep. Smith |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate